SAT0263 Comparison between TOCILIZUMAB and Alternatve TNF Inhibitor as A Second Line following TNF Inhibitor Failure in Patients with Rheumatoid Arthritis
Poster Presentations. Rheumatoid arthritis - other biologic treatment
SAT0263 Comparison between TOCILIZUMAB and Alternatve TNF Inhibitor as A Second Line following TNF Inhibitor Failure in Patients with Rheumatoid Arthritis